BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 84774)

  • 1. [Dysfunctional uterine bleeding. Hormonal management with chlormadinone acetate].
    Olivas Mendoza G; Santos Martínez A; Corral Olaguez M; Iduñate y Carlos DM; Hernández Ayup S
    Ginecol Obstet Mex; 1978 Dec; 44(266):463-71. PubMed ID: 84774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estrogen-gestagen therapy with hormonally induced uterine bleeding. II. Therapeutic use of Klimovan].
    Cséffalvay T; Klose S
    Dtsch Gesundheitsw; 1965 Jul; 20(29):1334-9. PubMed ID: 5319408
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of treatment of patients with dysfunctional uterine hemorrhages with different types of synthetic progestins].
    Sotnikova EI
    Sov Med; 1975 Jun; (6):31-5. PubMed ID: 1162470
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding--a double-blind randomized control study.
    DeVore GR; Owens O; Kase N
    Obstet Gynecol; 1982 Mar; 59(3):285-91. PubMed ID: 6281704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chlormadinone therapy of menstruation disorders].
    Stanev S; Trepechov S
    Akush Ginekol (Sofiia); 1973; 12(2):110-5. PubMed ID: 4128262
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
    Bernard I
    Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the behavior of the hemostatic system during hormonal treatment of menstruation disorders].
    Musiatowicz J; Bielecki M; Jezuita J; Wielkopolan J
    Wiad Lek; 1968 Jul; 21(13):1119-23. PubMed ID: 5670518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of synthetic steroid preparations for hemostasis and normalization of menstrual function in juvenile hemorrhages].
    Kuznetsova MN; Antipina NN; Zagorskaia EA
    Vopr Okhr Materin Det; 1978 Feb; 23(2):77-80. PubMed ID: 347706
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lutenyl and menstrual disorders. A hospital study].
    Cohen A; Engelmann P; Erny R; Favier M; Ghéron G
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):741-3. PubMed ID: 3206099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sequential treatment in menstrual irregularities and ovulation disorders].
    Bernard I
    Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(3):255-7. PubMed ID: 4164207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of menopause disorders by the sequential method].
    Gaudefroy M
    J Sci Med Lille; 1970 Dec; 88(12):637-49. PubMed ID: 4100661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the system of progesterone liberation in uterol in dysfunctional uterine bleeding].
    Ruiz Velasco V; Martínez Manautou J; Illanes Amurrio S; Maqueo Topete M; Conde de Vargas BI
    Ginecol Obstet Mex; 1974 Aug; 36(214):115-27. PubMed ID: 4430447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional uterine bleeding.
    Smith SK
    Br J Hosp Med; 1985 Dec; 34(6):351-4. PubMed ID: 4084703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the effectiveness of a new gestagen in the treatment of bleeding anomalies. A clinical contribution to the problem of oral gestagen therapie].
    Thewanger W
    Wien Klin Wochenschr; 1965 Jun; 77(25):468-9. PubMed ID: 5319349
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
    Krause W; Böhm W; Müller W
    Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
    [No Abstract]   [Full Text] [Related]  

  • 17. [Norethisterone acetate in the therapy of functional hemorrhages of the endometrium].
    Montemagno U
    Arch Ostet Ginecol; 1968; 73(4):421-40. PubMed ID: 5718494
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with a gestagen-estrogen preparation (AK 103=Aconcen)].
    Kalchauer B
    Ther Ggw; 1966 Jul; 105(7):938-9. PubMed ID: 4162578
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of dysfunctional uterine hemorrhage with 6-chloro-6-dehydro-17-alpha-acetoxyprogesterone].
    CASARES PONCE HJ
    Medicina (Mex); 1963 Mar; 43():136-40. PubMed ID: 14019046
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormal uterine bleeding.
    Connell A
    Nurse Pract; 1989 Apr; 14(4):40, 43-4, 47 passim. PubMed ID: 2652003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.